Notes
QUICK MARKET SUMMARY:
CONSUMER:
🔸 Colgate ( $CL): New $5B buyback, dividend to $0.52.
🔸 $NCLH: Upgraded to Equal Weight (Morgan Stanley).
🔸 Lennar ( $LEN): Q1 EPS $2.14 (est. $1.73), rev $7.63B (est. $7.49B); Q2 orders 22.5k-23.5k, deliveries 19.5k-20.5k.
🔸 Nike ( $NKE): Q3 EPS $0.54 (est. $0.28), rev $11.3B (est. $11.03B); guides Q4 rev down mid-teens.
🔸 $NIO: Q4 rev $2.7B (est. $2.79B), EV deliveries up 45%; Q1 guide: 41k-43k vehicles, rev $1.69B-$1.76B (est. $2.48B).
🔸 Torrid ( $CURV): Q4 sales -6.1% y/y; guides Q1 sales $264M-$274M (est. $279M), EBITDA below estimates.
🔸 Target ( $TGT): Files $1B note offering due 2035.
Energy/Industrials/Materials:
🔸 FedEx ( $FDX): Q3 EPS $4.51 (miss), rev $22.2B (beat); cuts FY25 guidance.
🔸 Nucor ( $NUE): Q1 EPS guide $0.50-$0.60 (est. $1.09); sees lower steel product prices.
🔸 Planet Labs ( $PL): Q4 loss -$0.08 (est. -$0.02), rev $61.6M; Q1 guide below est.
🔸 U.S. Steel ( $X): Q1 EBITDA $125M (in line), EPS loss guided larger than est.
🔸 BP ( $BP): Elliott pushes for cost cuts, possible board changes (Reuters).
Healthcare:
🔸 Assembly Bio ( $ASMB): Files $250M mixed shelf.
🔸 Editas ( $EDIT): CFO stepping down.
🔸 Foghorn ( $FHTX): Files $100M shelf.
🔸 J&J ( $JNJ): Plans $55B investment in U.S. manufacturing/research.
🔸 Maravai ( $MRVI): Guides Q1 rev $43M-$45M (est. $63M).
🔸 Vor Bio ( $VOR): Files $350M shelf.
Tech/Media/Telecom:
🔸 Micron ( $MU): Q2 EPS $1.56 (beat), rev $8.05B; Q3 guide above est.
🔸 Luminar ( $LAZR): Sees slower Q1, FY25 rev growth 10%-20%.
🔸 Quantum ( $QUBT): Q4 loss -$0.47 (miss), rev $62k; chip foundry launch in 2025.
🔸 Super Micro ( $SMCI): Upgraded to Neutral (JPM), price target raised to $45.
STOCKS ON THE MOVE
Lamb Weston ( $LW): Shares dropped after naming Michael Smith as CEO on Jan 3, following activist investor Jana Partners' push for board changes or a sale. LW cut FY sales forecast to $6.35B-$6.45B from $6.6B-$6.8B after Q2 sales fell 8% to $1.6B; approved $250M buyback.
Lennar Corp. ( $LEN): Q4 revenue down 9.3% to $9.95B, below estimates. New orders dropped 2.7% to 16,895, backlog down 22%. Forecasts Q1 new orders at 17,500-18,000, deliveries at 17,000-17,500.
MillerKnoll Inc. ( $MLKN): Q2 EPS $0.55 vs. $0.56 est., sales up 2.2% to $970.4M. Gross margin fell to 38.8%. Guides Q3 sales $903M-$943M, EPS $0.41-$0.47.
Steelcase ( $SCS): Q3 EPS $0.30 vs. $0.22 est., sales up 2.2% to $794.9M. Q4 guidance EPS $0.20-$0.24, revenue $770M-$795M.
Stanley Black & Decker ( $SWK): Upgraded to Outperform by Mizuho, price target $110, added to top picks.
Tri-Pointe Homes ( $TPH): Announced $250M stock buyback program.
Swiss Watch Exports: November exports down 3.8% to CHF 2.41B, with U.S. as the only top market increasing by 4.7%.
Palantir Technologies ( $PLTR): Extended U.S. Army contract worth up to $618.9M to enhance data operations, continuing data and AI support since 2018.
Block ( $SQ): Upgraded to Outperform by Oppenheimer with a $115 target, citing growth in Square's Gross Payment Volume due to product and sales investments.
Raymond James ( $RJF): November client assets under administration at $1.60T (+3.6% m/m), financial assets under management at $251.7B (+4.4% m/m).
Synchrony ( $SYF): Upgraded to Overweight from Underweight by Morgan Stanley.
Mesoblast ( $MESO): Shares up after FDA approval of Ryoncil for treating GVHD in pediatric patients not responding to steroids.
Prothena ( $PRTA): Phase IIb PADOVA study by Roche on prasinezumab for early Parkinson's missed its primary endpoint after 18 months.
Vertex Pharmaceuticals ( $VRTX): Phase 2 study of suzetrigine in LSR met primary endpoint with significant pain reduction; plans for Phase 3 advancement.
Micron Technology ( $MU): Q1 adj EPS $1.79 vs. $1.76 est., revenue up 84% to $8.71B. Shares fell after hours due to Q2 forecast below expectations: revenue $7.7B-$8.1B vs. $8.99B est., gross margin 37.5%-39.5% vs. 41.3% est., EPS $1.33-$1.53 vs. $1.92 est. FY25 capex about $14B. Memory stocks STX, WDC also dropped.
Accenture ( $ACN): Q1 EPS $3.59 vs. $3.42 est., revenue up 9% to $17.69B vs. $17.15B est. Operating margin at 16.7%. Lowered FY EPS guidance to $12.43-$12.79 from $12.55-$12.91.
Keybanc: Upgraded Okta ( $OKTA) and Fortinet ( $FTNT) to Overweight, downgraded https://t.co/n5rFzz3Pbq (AI) to Underweight.
U.S. Commerce Department: Awarded SK Hynix up to $458M for an advanced chip plant and R&D facility in Indiana for AI.
HBO这么随意地扯淡,于是买入 $Len 9WuADsQtSPQCA18xan5PJj8m1t82bQeUkLoLssS2pump
永远的中本聪
Who else is hyped for @HBODocs’ #Satoshi reveal in 'Money Electric:The Bitcoin Mystery'? 👀
Trade related meme coins on #BitgetWallet!
$LEN +4.7%
$ADAM +545.9%
$WAAS +5535.92%
Go to Bitget Wallet > Markets > Search for the latest Satoshi Nakamoto-concept coins!
WHO HAS NEVER WON YET?
FIRST 1000 REACTIONS WILL BE CONSIDERED 🫶
First 222 people to retweet gets free #SOL (yes, for real) 👀
👁️🗨️ $BASED next target is 40M MC. It's a fcking gem, i already bought 50sol and gonna buy another 200 $SOL
The narrative is too strong to be missed
$BASED : MAKE AMERICA BASED AGAIN
ca - APXEzWaC12YAejZr1v4sBhTcJMosGSA6oV5aTn9Jpump
https://t.co/5XSPxbvNwN
Hearing Len Sassaman is actually the founder of BTC...
If this is true on the 8th once HBO releases it this should easily send, no doubt.
I've been looking for a good entry on $LEN
I want to give the community one more test
100 likes & I'll buy a bag
I always keep my promise @Lensolana_

𝗜𝗡𝗧𝗘𝗥𝗔𝗖𝗧, 𝗠𝗜𝗚𝗛𝗧 𝗝𝗨𝗦𝗧 𝗖𝗛𝗔𝗡𝗚𝗘 𝗬𝗢𝗨𝗥 𝗟𝗜𝗙𝗘
Drop your $SOL address 👇
I just bought 30 $SOL worth $BASED! & More buys incoming
dev wallet connected with 8 figure crypto, been cooking for years!
After doing 100x on $manyu $giga $popcat $wif $pochita $len , $BASED is another easy win
MAKE AMERICA BASED AGAIN
$BASED is live now !
ca - APXEzWaC12YAejZr1v4sBhTcJMosGSA6oV5aTn9Jpump
Chart- https://t.co/o0Fvw0slIo
This could be the ultimate gamechanger gem, that could pump 100x within a day!
The best move? Going all in!

